Description
Report Summary
Molecular Diagnostics-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole India and Regional Market Size of Molecular Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Molecular Diagnostics in India, with company and product introduction, position in the Molecular Diagnostics market
Market status and development trend of Molecular Diagnostics by types and applications
Cost and profit status of Molecular Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the India Molecular Diagnostics market as:
India Molecular Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North India
Northeast India
East India
South India
West India
India Molecular Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PCR
DNA Sequencing
NGS
India Molecular Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Infectious Disease (Hepatitis, HIV)
Oncology
Genetic Testing
India Molecular Diagnostics Market: Players Segment Analysis (Company and Product introduction, Molecular Diagnostics Sales Volume, Revenue, Price and Gross Margin):
ABBOTT LABORATORIES
AGILENT TECHNOLOGIES
BECTON, DICKINSON AND COMPANY
BIOMERIEUX
DANAHER
DIASORIN
GRIFOLS
HOLOGIC
ILLUMINA
QIAGEN
ROCHE DIAGNOSTICS
SIEMENS
THERMO FISHER SCIENTIFIC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of contents
Table of Contents
Chapter 1 Overview of Molecular Diagnostics
1.1 Definition of Molecular Diagnostics in This Report
1.2 Commercial Types of Molecular Diagnostics
1.2.1 PCR
1.2.2 DNA Sequencing
1.2.3 NGS
1.3 Downstream Application of Molecular Diagnostics
1.3.1 Infectious Disease (Hepatitis, HIV)
1.3.2 Oncology
1.3.3 Genetic Testing
1.4 Development History of Molecular Diagnostics
1.5 Market Status and Trend of Molecular Diagnostics 2013-2023
1.5.1 India Molecular Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023
Chapter 2 India Market Status and Forecast by Regions
2.1 Market Status of Molecular Diagnostics in India 2013-2017
2.2 Consumption Market of Molecular Diagnostics in India by Regions
2.2.1 Consumption Volume of Molecular Diagnostics in India by Regions
2.2.2 Revenue of Molecular Diagnostics in India by Regions
2.3 Market Analysis of Molecular Diagnostics in India by Regions
2.3.1 Market Analysis of Molecular Diagnostics in North India 2013-2017
2.3.2 Market Analysis of Molecular Diagnostics in Northeast India 2013-2017
2.3.3 Market Analysis of Molecular Diagnostics in East India 2013-2017
2.3.4 Market Analysis of Molecular Diagnostics in South India 2013-2017
2.3.5 Market Analysis of Molecular Diagnostics in West India 2013-2017
2.4 Market Development Forecast of Molecular Diagnostics in India 2017-2023
2.4.1 Market Development Forecast of Molecular Diagnostics in India 2017-2023
2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2017-2023
Chapter 3 India Market Status and Forecast by Types
3.1 Whole India Market Status by Types
3.1.1 Consumption Volume of Molecular Diagnostics in India by Types
3.1.2 Revenue of Molecular Diagnostics in India by Types
3.2 India Market Status by Types in Major Countries
3.2.1 Market Status by Types in North India
3.2.2 Market Status by Types in Northeast India
3.2.3 Market Status by Types in East India
3.2.4 Market Status by Types in South India
3.2.5 Market Status by Types in West India
3.3 Market Forecast of Molecular Diagnostics in India by Types
Chapter 4 India Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Molecular Diagnostics in India by Downstream Industry
4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in North India
4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Northeast India
4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in East India
4.2.4 Demand Volume of Molecular Diagnostics by Downstream Industry in South India
4.2.5 Demand Volume of Molecular Diagnostics by Downstream Industry in West India
4.3 Market Forecast of Molecular Diagnostics in India by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Molecular Diagnostics
5.1 India Economy Situation and Trend Overview
5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview
Chapter 6 Molecular Diagnostics Market Competition Status by Major Players in India
6.1 Sales Volume of Molecular Diagnostics in India by Major Players
6.2 Revenue of Molecular Diagnostics in India by Major Players
6.3 Basic Information of Molecular Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players
6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Molecular Diagnostics Major Manufacturers Introduction and Market Data
7.1 ABBOTT LABORATORIES
7.1.1 Company profile
7.1.2 Representative Molecular Diagnostics Product
7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ABBOTT LABORATORIES
7.2 AGILENT TECHNOLOGIES
7.2.1 Company profile
7.2.2 Representative Molecular Diagnostics Product
7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of AGILENT TECHNOLOGIES
7.3 BECTON, DICKINSON AND COMPANY
7.3.1 Company profile
7.3.2 Representative Molecular Diagnostics Product
7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BECTON, DICKINSON AND COMPANY
7.4 BIOMERIEUX
7.4.1 Company profile
7.4.2 Representative Molecular Diagnostics Product
7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BIOMERIEUX
7.5 DANAHER
7.5.1 Company profile
7.5.2 Representative Molecular Diagnostics Product
7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DANAHER
7.6 DIASORIN
7.6.1 Company profile
7.6.2 Representative Molecular Diagnostics Product
7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DIASORIN
7.7 GRIFOLS
7.7.1 Company profile
7.7.2 Representative Molecular Diagnostics Product
7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GRIFOLS
7.8 HOLOGIC
7.8.1 Company profile
7.8.2 Representative Molecular Diagnostics Product
7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of HOLOGIC
7.9 ILLUMINA
7.9.1 Company profile
7.9.2 Representative Molecular Diagnostics Product
7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ILLUMINA
7.10 QIAGEN
7.10.1 Company profile
7.10.2 Representative Molecular Diagnostics Product
7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN
7.11 ROCHE DIAGNOSTICS
7.11.1 Company profile
7.11.2 Representative Molecular Diagnostics Product
7.11.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of ROCHE DIAGNOSTICS
7.12 SIEMENS
7.12.1 Company profile
7.12.2 Representative Molecular Diagnostics Product
7.12.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of SIEMENS
7.13 THERMO FISHER SCIENTIFIC
7.13.1 Company profile
7.13.2 Representative Molecular Diagnostics Product
7.13.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of THERMO FISHER SCIENTIFIC
Chapter 8 Upstream and Downstream Market Analysis of Molecular Diagnostics
8.1 Industry Chain of Molecular Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Molecular Diagnostics
9.1 Cost Structure Analysis of Molecular Diagnostics
9.2 Raw Materials Cost Analysis of Molecular Diagnostics
9.3 Labor Cost Analysis of Molecular Diagnostics
9.4 Manufacturing Expenses Analysis of Molecular Diagnostics
Chapter 10 Marketing Status Analysis of Molecular Diagnostics
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
